Health Jeune Aesthetics Announces Dosing of First Subject in Phase 1, Cohort 3 Study of KB301 for the… Jason Junior Apr 18, 2023 <!-- Name:DistributionId Value:8809857 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value:5500 -->…
Business Galderma Announces Positive Results in Two Phase III Studies for a Novel Liquid Formulation… Kemal Pasha Jun 11, 2022 This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content.…